Results 101 to 110 of about 8,213 (208)

Detection of coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction

open access: yes, 1991
Coxsackievirus B3 is a possible etiologic agent in some forms of myocarditis and idiopathic dilated cardiomyopathy. A method for the detection of coxsackievirus B3 RNA was developed using the polymerase chain reaction based on the amplification of a cDNA
Billingham, M. E.   +3 more
core  

SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors

open access: yes, 2011
Coxsackievirus and related enteroviruses are important human pathogens that cause various diseases with clinical manifestations ranging from trivial flu-like syndromes to dangerous or even fatal diseases such as myocarditis, meningitis and encephalitis ...
Helena Mertlíková-Kaiserová   +17 more
core   +1 more source

Monthly distribution of coxsackievirus A4 (CA4), B3 (CB3) and B4 (CB4) isolates from January, 2004 to June, 2012 in Chang Gung Memorial Hospital, Taiwan.

open access: yes, 2014
Monthly distribution of coxsackievirus A4 (CA4), B3 (CB3) and B4 (CB4) isolates from January, 2004 to June, 2012 in Chang Gung Memorial Hospital, Taiwan.
Chia-Jie Lee (289823)   +7 more
core   +1 more source

Perinatal Coxsackievirus B3 Infection with Transient Thrombocytopenia

open access: yesThe Tohoku Journal of Experimental Medicine, 2016
Coxsackievirus (Cox) B is the second common picornaviruses, after echovirus, detected from children younger than 2 months of age. Neonates who present with Cox B3 infection in the first week are known to have severe illness such as myocarditis or menigoencephalitis. Severity is commonly associated with perinatal vertical transmission. Here, we report a
Kaga, Akimune   +6 more
openaire   +3 more sources

Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation

open access: yesViruses
Oncolytic viruses represent a paradigm-shifting approach to cancer immunotherapy, functioning as in situ vaccines that convert immunologically “cold” tumors into “hot” tumors through induction of immunogenic cell death (ICD). Despite the clinical success
Hiroyuki Inoue
doaj   +1 more source

Adenosine triphosphate is an allosteric inhibitor of coxsackievirus B3 3Dpol [PDF]

open access: yes, 2016
2016 Spring.Includes bibliographical references.Picornaviruses pose a significant threat to human and animal health, but at present there are no drugs to prevent or treat picornaviral infections. However, intensive study of the picornaviral lifecycle has
Cohen, Robert, committee member   +3 more
core  

High proportion of coxsackievirus B3 genotype A in hand, foot and mouth disease in Zhenjiang, China, 2011–2016

open access: yesInternational Journal of Infectious Diseases, 2019
Background: Hand, foot and mouth disease (HFMD) is usually caused by EVA71 and CVA16 except for a few cases that are caused by non-EVA71 non-CAV16 enteroviruses.
Xuemin Fu   +7 more
doaj   +1 more source

IL-9 inhibits viral replication in Coxsackievirus B3-induced myocarditis

open access: yesFrontiers in Immunology, 2016
Myocardial injuries in viral myocarditis (VMC) are caused by viral infection and related autoimmune disorders. Recent studies suggest that IL-9 mediated both antimicrobial immune and autoimmune responses in addition to allergic diseases.
Miao Yu   +6 more
doaj   +1 more source

Study on the inhibitory effect of geniposide on coxsackievirus and its mechanism

open access: yesFrontiers in Pharmacology
BackgroundCoxsackievirus infection can cause various diseases such as myocarditis and encephalitis, posing a serious threat to human health. However, there are currently no specific therapeutic drugs or effective vaccines for Coxsackievirus infection, so
Jianbo Xia, Zuliang Shi, Mengxin Shen
doaj   +1 more source

Apoptoseprozesse in der Pathogenese viraler Infektionen: Interaktion des Kapsidproteins VP2 von Coxsackievirus B3 mit dem proapoptotischen Protein SIVA

open access: yes, 2003
Gegenstand dieser Promotionsarbeit waren die zellulären Ereignisse im Verlauf einer Infektion mit Coxsackievirus B3. Das Capsidprotein VP2 von Coxsackievirus B3 interagiert mit einem bis dahin wenig erforschten Protein.
Nestler, Matthias
core  

Home - About - Disclaimer - Privacy